Hyoscine Butylbromide Crescent Pharma

Hyoscine Butylbromide, the active ingredient in Hyoscine Butylbromide Crescent Pharma, is an anticholinergic antispasmodic presented as an oral formulation for oral use. It relieves smooth‑muscle spasm in the gastrointestinal tract and is used to treat abdominal cramps, colic and related pain.

GNH USA supplies Hyoscine Butylbromide Crescent Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hyoscine Butylbromide acts on smooth‑muscle spasm in the gastrointestinal and biliary systems, providing relief in several conditions. - Abdominal cramps: reduces intensity and frequency of painful contractions. - Irritable bowel syndrome: alleviates cramping and abdominal discomfort. - Renal colic: eases spasm of the ureteral smooth muscle. - Biliary colic: relaxes biliary tract smooth muscle to lessen pain. - Menstrual pain: diminishes uterine smooth‑muscle cramps.

Hyoscine Butylbromide may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth - Blurred vision - Constipation - Urinary retention - Tachycardia - Dizziness

Serious or Rare Side Effects: - Allergic reactions (rash, itching, swelling) - Severe skin rash or Stevens‑Johnson syndrome - Difficulty swallowing (dysphagia) - Severe constipation or paralytic ileus - Cardiac arrhythmia - Acute glaucoma exacerbation

Before prescribing Hyoscine Butylbromide, consider the following safety measures. - Assess renal function: adjust use in severe renal impairment. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Caution in glaucoma patients: anticholinergic effect may raise intra‑ocular pressure. - Use carefully in elderly: higher risk of anticholinergic side effects. - Pregnancy and lactation: safety not established; consult physician. - Store at ambient temperature: keep in original container, protect from moisture.

Hyoscine Butylbromide can interact with several drug classes, requiring attention to avoid additive effects.

Major Interactions (Avoid): - Anticholinergic agents: additive anticholinergic burden. - Tricyclic antidepressants: increased anticholinergic side effects. - Antihistamines: enhanced dry mouth and constipation. - Opioids: may potentiate constipation. - Antipsychotics with anticholinergic properties: increased risk of side effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia. - CYP3A4 inhibitors: possible increase in plasma levels. - Alcohol: may intensify dizziness. - Diuretics: risk of urinary retention. - Anticholinesterase drugs: reduced efficacy of Hyoscine Butylbromide.